1. Home
  2. SPT vs AVXL Comparison

SPT vs AVXL Comparison

Compare SPT & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SPT

Sprout Social Inc

HOLD

Current Price

$6.37

Market Cap

327.6M

Sector

Technology

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$3.09

Market Cap

289.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPT
AVXL
Founded
2010
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
327.6M
289.1M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
SPT
AVXL
Price
$6.37
$3.09
Analyst Decision
Buy
Strong Buy
Analyst Count
8
3
Target Price
$11.75
$22.00
AVG Volume (30 Days)
1.4M
863.0K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
32.11
N/A
EPS
N/A
N/A
Revenue
$457,547,000.00
N/A
Revenue This Year
$8.86
N/A
Revenue Next Year
$8.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.72
N/A
52 Week Low
$4.92
$2.61
52 Week High
$23.56
$13.99

Technical Indicators

Market Signals
Indicator
SPT
AVXL
Relative Strength Index (RSI) 51.32 40.92
Support Level $6.03 $2.93
Resistance Level $7.39 $3.50
Average True Range (ATR) 0.42 0.18
MACD 0.04 -0.01
Stochastic Oscillator 38.01 16.33

Price Performance

Historical Comparison
SPT
AVXL

About SPT Sprout Social Inc

Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: